Graf Akcie IART (Integra Lifesciences Holdings Corp). Diskuze k akciím IART. Aktuální informace IART.

Základní informace o společnosti Integra Lifesciences Holdings Corp (Akcie IART)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 5.64B
Hodnota podniku (EV) 7.02B
Tržby 1.509B
EBITDA 214.187M
Zisk 205.543M
Růst v tržbách Q/Q 50.77 %
Růst v tržbách Y/Y 8.78 %
P/E (Cena vůči ziskům) 27.97
Forward P/E 0.04
EV/Sales 4.65
EV/EBITDA 32.79
EV/EBIT 27.36
PEG 1.86
Price/Sales 3.74
P/FCF 19.98
Price/Book 3.72
Účetní hodnota na akcii 18.19
Hotovost na akcii 5.64
FCF vůči ceně 5.00 %
Počet zaměstnanců 3,700
Tržba na zaměstnance 407.822k
Profit margin 9.76 %
Operating margin 12.77 %
Gross margin 62.03 %
EBIT margin 17.02 %
EBITDA margin 14.19 %
EPS - Zisk na akcii 2.42
EPS - Kvartální růst 139.39 %
EPS - Očekávaný růst příští rok -8.75 %
Return on assets 5.66 %
Return on equity 13.66 %
ROIC 4.77 %
ROCE 7.56 %
Dluhy/Equity 1.39
Čistý dluh/EBITDA 23.42
Current ratio 3.24
Quick Ratio 2.22
Volatilita 2.63
Beta 1.14
RSI 43.57
Cílová cena analytiků 57
Známka akcie (dle analytiků) 2.08
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 84.58M
Procento shortovaných akcií 6.94 %
Short ratio 11.21 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1995
Země United States

Finanční výsledky akcie IART

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,371.868$1,517.557$1,472.441$1,188.236$992.075$882.734
Cost Of Goods Sold$520.834$564.681$571.496$435.511$349.089$326.542
Gross Profit$851.034$952.876$900.945$752.725$642.986$556.192
Research And Development Expenses$77.381$79.573$78.041$63.455$58.155$50.895
SG&A Expenses$594.526$687.599$690.746$624.096$455.629$415.757
Other Operating Income Or Expenses------
Operating Expenses$1,220.498$1,423.797$1,361.443$1,143.432$876.735$803.147
Operating Income$151.37$93.76$110.998$44.804$115.34$79.587
Total Non-Operating Income/Expense$-57.85$-33.656$-53.595$-33.419$-24.934$-18.916
Pre-Tax Income$93.52$60.104$57.403$11.385$90.406$60.671
Income Taxes$-40.372$9.903$-3.398$-53.358$15.842$53.82
Income After Taxes$133.892$50.201$60.801$64.743$74.564$6.851
Other Income------
Income From Continuous Operations$133.892$50.201$60.801$64.743$74.564$6.851
Income From Discontinued Operations-----$-10.37
Net Income$133.892$50.201$60.801$64.743$74.564$-3.519
EBITDA$294.892$208.612$227.998$136.471$190.534$140.714
EBIT$151.37$93.76$110.998$44.804$115.34$79.587
Basic Shares Outstanding858683777469
Shares Outstanding858684797971
Basic EPS$1.58$0.59$0.73$0.84$1.00$-0.05
EPS - Earnings Per Share$1.57$0.58$0.72$0.82$0.94$-0.05
# 2020 2019 2018 2017 2016 2015
Current Ratio3.08522.59022.95212.35634.00623.1518
Long-term Debt / Capital0.48180.47910.49190.64920.4420.4823
Debt/Equity Ratio1.02610.95150.98431.91330.7920.9508
Gross Margin62.034762.790161.187263.348164.812263.0079
Operating Margin11.03396.17837.53843.770611.62619.016
EBIT Margin11.03396.17837.53843.770611.62619.016
EBITDA Margin21.495713.746615.484411.485219.205615.9407
Pre-Tax Profit Margin6.8173.96063.89850.95819.11286.8731
Net Profit Margin9.75983.3084.12935.44877.516-0.3986
Asset Turnover0.37950.45940.47380.370.54870.4975
Inventory Turnover Ratio1.67951.78672.03851.46971.60681.5445
Receiveable Turnover6.08285.51255.5414.7196.69486.6752
Days Sales In Receivables60.005266.213765.872977.347154.5254.6801
ROE - Return On Equity8.83853.54344.41936.72798.88020.9117
Return On Tangible Equity-32.9025-8.8206-9.6483-5.7031-32.1287-1.8786
ROA - Return On Assets3.70371.51981.95632.01614.12420.3861
ROI - Return On Investment4.58051.84582.24562.35994.95550.472
Book Value Per Share17.962116.498616.154912.275311.237510.2455
Operating Cash Flow Per Share-0.28410.29850.9295-0.02220.00040.2018
Free Cash Flow Per Share0.1060.41550.55510.0254-0.14520.3353